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Abstract
Background Gaps in computerized medical records and a
lack of a systematic approach to data recording make pro-
gress towards achieving quality standards in primary care
difficult to demonstrate. The aim of this study was to exam-
ine the effect of an educational intervention on data quality in
primary care.
Methods A before-and-after study of key data quality 
measures was carried out in 87 general practices in eight 
primary care organizations in England in phase 1 and 84 
general practices in phase 2. The subjects were 19 470 patients
with ischaemic heart disease in phase 1 and 19 784 patients in
phase 2. The main outcome measures were improvement in
the completeness and quality of the computerized medical
record. Anonymized data were extracted from clinical infor-
mation systems and processed to produce comparative 
information on each practice. Data quality workshops were
arranged, in which reflection can take place, backed up by
summary statistics. Practice visits provided training and 
personalized feedback of patients needing intervention.
Results In the patients with heart disease, nearly 16 000 new
clinical entries were made in the key improvement areas.
The percentage of patients advised to quit smoking increased
by 49.3 per cent, from 23.6 per cent to 61.9 per cent. There
were also significant improvements in many other aspects of
management.
Conclusions Focused interventions that provide targeted
and relevant clinical information can be implemented in 
primary care. Such interventions can lead to a rise in data
quality in primary care, but their effectiveness needs to be
further tested in more rigorous research settings such as 
randomized controlled trials.
Keywords: primary care, quality improvement, secondary
prevention of coronary heart disease, computerized medical
records
Introduction
Health care systems across the world are trying to improve the
quality of care they provide. One area with considerable scope
for improvement is the implementation of secondary prevention
in patients with ischaemic heart disease.1,2 This paper describes
the use of an audit-based data quality initiative to address this
deficiency.
Much of the information required to audit the quality of care
given will come from the computerized medical records held by
general practitioners (GPs). At present, these records are often
incomplete and inaccurate.3 There are a number of reasons for
this, including a lack of training and support in using clinical
information systems. However, there is relatively little pub-
lished on initiatives to improve data quality in primary care.
In this paper, we describe the first results of a programme to
improve the quality and completeness of information recorded on
patients with ischaemic heart disease in eight primary care organ-
izations. We chose to study ischaemic heart disease because it is a
common condition, there is good evidence about the effectiveness
of treatments for it, and primary care has an important role to
play in its management. The objectives were to see if a structured
data quality improvement programme could lead to improve-
ments in data quality in primary care and to identify lessons that
could be applied by other primary care organizations.
Methods
The Primary Care Data Quality (PCDQ) Programme is an 
educational intervention targeted at primary care professionals,
which is designed to improve data recording on general prac-
tices’ computer systems.4 The PCDQ Programme aims to build
upon existing skills and knowledge for recording data within
primary care and to maximize the use of technology to monitor
and assess improvements in the quality of data. The package
includes support for the installation of Morbidity, Information
Query and Export Syntax (MIQUEST), a program that extracts
data from computerized medical records in primary care. 
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Training in the use of Read codes5 is also provided to any clini-
cian who needs or requests it.
The programme’s only didactic session is a 1 hour intro-
ductory meeting. This is held with each primary care organiza-
tion, with representatives from every practice; ideally, one or
more GPs accompanied by their practice manager and nurse.
Anonymized data are then collected from the participating
practices using MIQUEST, and analysed and presented to 
primary healthcare professionals in a format that is easy for
them to interpret.6 This is done at baseline, and at least 
6-monthly thereafter in data quality workshops that last about
2–3 hours. The participants work in small groups to discuss the
findings and how they can improve both the quality of care and
data recording.
The MIQUEST software extracts data in the same formats
from different practice computer systems. In addition, the
PCDQ Programme produces written guidelines on how and
why to code information customized for each of the major 
versions of general practice software. Although these guidelines
include lists of suggested Read codes, the MIQUEST searches
used are designed to trawl widely to maximize the identification
of patients with ischaemic heart disease, even when ‘ideal’ Read
codes have not been used.
The MIQUEST queries also identify (to that practice only)
those patients who need intervention or changes in their treat-
ment. Lists can be produced by practice of patients who need
interventions such as cholesterol or blood pressure measure-
ment, aspirin or lipid-lowering drugs, or smoking advice. The
process is done with a minimum of effort from the participating
clinicians – all the practitioners have to do is to attend two meet-
ings in the year and have an on-site Read code training session if
they wish it. The small group work allows the clinicians to learn
more about data quality, how much unmet need there is in their
own practice and locality, and the extent of completeness of
their computerized medical records.
The PCDQ Programme deals with a deliberately small
dataset, the correct recording of the diagnosis of ischaemic heart
disease and the recording of four key measures of management.
These are blood pressure measurement,7–9 use of aspirin
prophylaxis,10 cholesterol measurement and control,11,12 and
recording of smoking status and advice to stop smoking.13
An incremental approach is taken as our preliminary discus-
sions revealed that many clinicians who do not already code data
on their computer systems do not do so because they are either
not in the habit of doing this or are uncomfortable about Read
coding clinical information.14 Many clinicians stated that asking
them to make a relatively small incremental step – such as coding
the diagnosis of ischaemic heart disease and four key areas of
management – would be more likely to achieve change than ask-
ing for ‘everything’ to be Read coded on their computer systems.
The participating clinicians know that at the next review
meeting, their progress in achieving the preliminary coding 
targets will be reviewed. The PCDQ Programme will only move
on to other areas (such as high-risk groups and co-morbidities,
coding of information on anti-coagulation treatment in people
with atrial fibrillation,15 beta-blockers in people with a history of
myocardial infarction,16 angiotensin-converting-enzyme inhib-
itors in people with heart failure17) once the collection basic
information has reached a satisfactory standard.
An introductory meeting is held before the first data collec-
tion, so that professionals within the primary care organization
can meet the PCDQ team members who will be working 
with then. This allows the participating clinicians to build a co-
operative relationship with the PCDQ team members and 
realize that what is being asked of them has already been
achieved by clinicians in other primary care organizations. One
clinician and one data collector are assigned to each primary
care organization the programme works with. To be successful
in achieving change, the PCDQ Programme needs to engage
almost every practice within the primary care organization. An
enthusiastic local lead is a significant help because they can help
encourage participation from other local clinicians.
The programme’s key event is the 6-monthly data quality
workshop, again ideally attended by a GP, nurse and manager
from each practice. The participants at the meeting learn from
presentation and then discussion of pooled, anonymized data.
The workshop seeks to draw out the knowledge about what has
been done to achieve better data quality from the participants.
Where adjudged by the group to be relevant to their learning
needs, the programme will build on skills in locating and
appraising evidence. Questionnaires completed at each step of
every workshop inform whether the presentation can be under-
stood and if it has had the required impact. In addition, there is
also input into individual practices.
Results
The first results of the PCDQ Programme are available from
eight primary care organizations, located in three NHS Regions.
These are based on a total practice population of 600 000, of
whom about 20 000 have ischaemic heart disease. There were 
87 practices in the first data collection and 84 in the second (the
decline in the number of practices was due to some upgrading to
computer systems that were not MIQUEST compatible). The
second data collections were all carried out between August
2000 and October 2001, between 6 and 8 months after the first
data collection.
The recorded prevalence of ischaemic heart disease increased
by about 10 per cent, from 29 to 32 per 1000 patients. Many of
the newly identified patients had very limited clinical informa-
tion coded and in many practices this therefore resulted initially
in a reduction in the proportion of patients with key data items
coded. Despite this, among the patients with ischaemic heart
disease, there has been a considerable overall increase in com-
puterized recording of new clinical data. Nearly 10 000 (50 per
cent) additional patients with ischaemic heart disease have been
recorded as being given advice to stop smoking, a further 2000
(10 per cent) have had their smoking habit recorded and their
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cholesterol measured, and nearly 1000 (5 per cent) have had
their aspirin status recorded (Table).
Discussion
The PCDQ Programme has shown how a focused educational
intervention can result in a modest but positive change in data
recording within primary care. A key factor in the success of the
programme appeared to be the leadership and involvement of
local clinicians. A visiting team, which has the technical and
educational expertise, proved to be a highly cost-effective
investment. Involvement in the PCDQ Programme for 1 year
cost the practice less than employing one full-time clerical 
member of staff; a strategy adopted by several of the partici-
pating primary care organizations before joining the PCDQ
Programme. Its costs are between £10 000 and £15 000 per year
depending on the size and geography of the locality.
The content of the data quality workshops focused on what
practical steps could be taken to improve data recording. This
included the training of clinicians by the programme’s data col-
lectors when they visited the practices, the use of our Read code
prompt cards, and whether the locality should employ more
nurses in the areas that needed to see greater improvement. The
last was sometimes contentious, with some practices believing
that receiving extra resources was rewarding poorly performing
practices. There was always debate over how to use nurse time
effectively, and whether nurses should be employed by the 
primary care organization or by individual general practices.
The educational approach, focused on a narrow clinical area
where there are interventions of known effectiveness that GPs
can make, appears to change data recording. The intervention
should also be generalizable, both within the United Kingdom
and elsewhere. The programme has now been implemented in 23
primary care organizations with very different characteristics.
Limitations of study
One limitation of the PCDQ Programme is that the primary
care organizations that participated were volunteers and were
actively looking for tools to help them raise standards. Some
had tried other means to collect the required data, but their pre-
vious approaches had either proved highly expensive or had
failed. Not surprisingly, all but one of this group of primary care
organizations had baseline levels of data recording higher than
that in a previous study.18
Another limitation of the study design is that we used a
‘before-and-after’ approach to evaluate the effectiveness of the
intervention. This means that there was no control group and
hence we cannot be certain that there was a causal relationship
between the PCDQ Programme and improvements in data
recording and quality of care.
There were also technical problems with the MIQUEST
interpreter software, especially in the lack of an effective inter-
preter for one of the major and several of the minor computer
systems. A central system of producing queries had advantages
in that it was possible to have staff constantly looking out for
changes in the Read classification, and for problems with a par-
ticular computer system’s interpreter. Personal relationships
have been established with the small number of programmers
who create the MIQUEST interface for their clinical system.
Data collected in a standard way by a query are also readily
comparable. The downside is that this is potentially less flexible
for the end user – although they still have the ordinary search
tool built into their clinical system.
Implications for policy and practice
Our findings suggest that the approach to similar programmes
should not be centred on technical issues such as adeptness at
extracting, processing and presenting data, but on the creation
of an environment in which what might work in a locality is 
discussed and then reflected upon. Much of that knowledge
appeared to be tacit and only shared when the appropriate
opportunity presented itself. Finally, ischaemic heart disease is a
disease area where the Read coding systems offers appropriate
terms. The evidence on management also lends itself to quanti-
tative recording (e.g. blood pressure, cholesterol, number of
Table Change in IHD data recording during phase 1 of the PCDQ Programme (numbers, with percentages
given in parentheses)
First data collection Second data collection Difference
Number of practices 87 84 –3
Total combined list size 643 890 600 424 –43 466
IHD subset population 19 470 (2.9) 19 784 (3.2) 314 (0.3)
Patients with BP record 17 889 (91.9) 18 136 (91.7) 247 (–0.2)
IHD patients taking aspirin 14 422 (74.1) 15 355 (77.6) 933 (3.5)
IHD patients with cholesterol reading 8871 (45.6) 10 885 (55.0) 2014 (9.5)
IHD with raised (>5 mmol) cholesterol 4394 (22.6) 5075 (25.7) 681 (3.1)
IHD with raised (>5 mmol) cholesterol
NOT taking a lipid-lowering drug 2110 (48.1) 2309 (45.5) 199 (–2.6)
IHD patients with smoking habit record 14 370 (73.8) 16 580 (83.8) 2210 (10.0)
IHD patients advised to quit smoking 2469 (12.7) 12 248 (61.9) 9779 (49.2)
BP, blood pressure; IHD, ischaemic heart disease.
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cigarettes smoked) and there are interventions – such as aspirin,
lipid-lowering drugs and anti-hypertensives – that primary care
clinicians can implement.19 These evidence-based decisions have
been demonstrated to have a far higher influence on outcome
than treatments in many other areas of primary care.20
Conclusions
The PCDQ Programme appears to be a successful educational
intervention. The programme was acceptable to GPs and par-
ticipation resulted in primary care professionals improving 
clinical care as well as learning how to share their knowledge
and expertise. It has resulted in a modest but clinically signifi-
cant increase in the identification of cases of ischaemic heart 
disease and in data recording on these patients in primary care.
Further evaluation of the PCDQ Programme using more 
rigorous research designs such as randomized controlled trials
will help determine if second and subsequent cycles lead to 
additional improvements in data recording in primary care.
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